Endothelin 1 (ET-1) is a potent vasoconstrictor peptide possibly involved in the pathophysiology of essential hypertension. We sought to determine whether the contribution of ET-1 to the regulation of basal vascular tone is increased in hypertensive patients (HTs). To this purpose, we compared the effect of intraarterial infusion of an ET/A-receptor blocker (BQ-123, 100 nmol/min for 60 min), alone and in combination with an ET/B-receptor blocker (BQ-788; 50 nmol/min for 60 min) in 7 normotensives (NTs) and 7 HTs. BQ-123 did not significantly change forearm blood flow (FBF; strain-gauge plethysmography) in NTs (2.6+/-0.4 before vs 2.5+/-0.7 mL/min/dL after BQ-123; P=0.50), but significantly increased FBF in HTs (from 2.9+/-1.3 at baseline to 4+/- 1.5 mL/min/dL; P<0.02). The addition of BQ-788 to BQ-123 infusion did not induce any significant change in FBF in NTs (2.4+/-0.9 mL/min/dL; P=0.71 vs BQ-123 alone), but produced an additional, though not significant, increase in FBF in HTs (to 5+/-1.7 mL/min/dL; P= 0.37 vs BQ-123 alone). To investigate the possibility of a different reactivity of vascular smooth muscle cells to ET-1, we compared the effect of exogenous ET-1 in NTs and HTs. ET-1 infusion (5 pmol/min for 60 min) significantly decreased FBF in both NTs (from 2.6+/-0.8 at baseline to 1.5+/-0.4 mL/min/dL; P<0.004) and in HTs (from 2.6+/-0.5 to 1.3+/-0.5 mL/min/dL; P<0.001), without significant difference between the 2 groups (P=0.31). These findings suggest an enhanced vasoconstrictor activity of ET-1 in HTs. This effect is not related to a greater sensitivity of the microvasculature to ET-1, but likely reflects increased local availability of the peptide.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Intramural Research (Z01)
Project #
1Z01HL005009-01
Application #
6162760
Study Section
Cell Biology Integrated Review Group (CB)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
National Heart, Lung, and Blood Institute
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Ingram, Jennifer L; Slade, David; Church, Tony D et al. (2016) Role of Matrix Metalloproteinases-1 and -2 in Interleukin-13-Suppressed Elastin in Airway Fibroblasts in Asthma. Am J Respir Cell Mol Biol 54:41-50
Lugogo, Njira L; Hollingsworth, John W; Howell, Druhan L et al. (2012) Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype. Am J Respir Crit Care Med 186:404-11
Ingram, Jennifer L; Huggins, Molly J; Church, Tony D et al. (2011) Airway fibroblasts in asthma manifest an invasive phenotype. Am J Respir Crit Care Med 183:1625-32